Persistent URL of this record https://hdl.handle.net/1887/106583
In Collections
This item can be found in the following collections:
![Unblinded Results from a dose-escalating placebo-controlled study with allogeneic bone marrow-derived mesenchymal stem cells for the treatment of refractory perianal fistulas in patients with Crohn's disease](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Unblinded Results from a dose-escalating placebo-controlled study with allogeneic bone marrow-derived mesenchymal stem cells for the treatment of refractory perianal fistulas in patients with Crohn's disease
- All authors
- Molendijk, I.; Bonsing, B.A.; Roelofs, H.; Peeters, K.C.; Wasser, M.N.; Veenendaal, R.A.; Zwaginga, J.J.; Verspaget, H.W.; Fibbe, W.E.; Meulen-de Jong, A.E. van der; Hommes, D.W.
- Date
- 2015-02-28
- Journal
- Journal of Crohn's and Colitis
- Volume
- 9
- Pages
- S254 - S255